In human trials, chlorogenic acid has been shown to reduce postprandial glucose and insulin responses during oral glucose tolerance tests, as well as improving fasting glucose levels and insulin sensitivity in individuals with impaired glucose tolerance [113]. Here, INS is linked to Impaired glucose tolerance.